"The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are"...
(Generic versions may still be available.)
Atromid-S Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Atromid-S (clofibrate capsules) is an antilipidemic drug used to lower high levels of cholesterol (a type of fat) in the blood. It is especially good at lowering triglycerides and very-low-density lipoprotein (VLDL) (a form of cholesterol). The brand name of this medication is discontinued, but generic versions may be available. Common side effects include bloating, flatulence, nausea, vomiting, diarrhea, headache, dizziness, drowsiness, or impotence.
The recommended dosage of Atromid-S for adults is 2 g daily in divided doses. Atromid-S may interact with anticoagulants, insulin or oral diabetes medications, or other cholesterol-lowering drugs. Tell your doctor all medications and supplements you use. Atromid-S may pass into the system of a fetus and can build up dangerously in unborn babies, who do not yet have the ability to break down and pass this drug from the body. Tell your doctor if you are pregnant before taking Atromid-S. This drug passes into breast milk. Since babies do not yet have the ability to break down this drug, a dangerous buildup could occur. Consult your doctor before breastfeeding.
Our Atromid-S (clofibrate capsules) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Atromid-S FDA Prescribing Information: Side Effects
The most common is nausea. Less frequently encountered gastrointestinal reactions are vomiting, loose stools, dyspepsia, flatulence, and abdominal distress. Reactions reported less often than gastrointestinal ones are headache, dizziness, and fatigue; muscle cramping, aching, and weakness; skin rash, urticaria, and pruritus; dry brittle hair, and alopecia.
The following reported adverse reactions are listed alphabetically by systems:
Increased or decreased angina.
Both swelling and phlebitis at site of xanthomas.
Allergic reactions including urticaria.
Dry skin and dry, brittle hair.
Toxic epidermal necrolysis.
Gastrointestinal upset (bloating, flatulence, abdominal distress).
Hepatomegaly (not associated with hepatotoxicity).
Stomatitis and gastritis.
Potentiation of anticoagulant effect.
Myalgia (muscle cramping, aching, weakness).
Rhabdomyolysis in the setting of preexisting renal insufficiency.
Fatigue, weakness, drowsiness.
Increased creatine phosphokinase.
Reported adverse reactions whose direct relationship with the drug has not been established: peptic ulcer, gastrointestinal hemorrhage, rheumatoid arthritis, tremors, increased perspiration, systemic lupus erythematosus, blurred vision, gynecomastia, thrombocytopenic purpura.
Read the entire FDA prescribing information for Atromid-S (Clofibrate)
Additional Atromid-S Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.